Oceanside, California USA, Jan 11 – AOTI Inc. announced today that it will be providing an expansive Clinical Education program at the Desert Foot conference, East and Midwest Podiatric Residency summits, which are the leading conferences focused on the Veterans Administration and other Federal Government segments.
“These three congresses provide an unparalleled opportunity to educate clinicians on the clinical evidence and benefits of our patented Topical Wound Oxygen therapy” stated Dr. Mike Griffiths, CEO and President of AOTI Ltd. “providing AOTI an ideal venue to demonstrate the true value of its revolutionary wound care products to key clinicians and providers from across the USA”
[raw]
[column size=”1/3″ wpautop=”true”]
[/column]
[column size=”1/3″ wpautop=”true”]
[/column]
[column size=”1/3″ wpautop=”true” last]
[/column]
[clear]
[/raw]
About AOTI
AOTI Inc. is a leading international company providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is unsurpassed in fully closing Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Oceanside, California USA and Galway, Ireland with offices throughout the globe. For more information, see www.aotinc.net
